Taro Pharmaceutical Industries Ltd.
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: -
TARO
Taro Pharmaceutical Industries Ltd.
GICS: -
·
Sektor: Healthcare
·
Sub-Sektor: Drug Manufacturers—Specialty & Generic
NAME
Taro Pharmaceutical Industries Ltd.
ISIN
IL0010827181
TICKER
TARO
MIC
XSTU
REUTERS
TARO.N
BLOOMBERG
TARO US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Di., 24.09.2024
Taro Pharmaceutical
IL0010827181
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for...
Taro Pharmaceutical
Mo., 16.09.2024
Taro Pharmaceutical
IL0010827181
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for ...
Taro Pharmaceutical
Mo., 16.09.2024
Taro Pharmaceutical
IL0010827181
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) for violations of the federal securities laws.
Investors who purchased the Company's securities pursuant and/or traceable to the Company’s Offering Do...
Taro Pharmaceutical
Mo., 16.09.2024
Taro Pharmaceutical
IL0010827181
The sixth paragraph of the release has been replaced.
The updated release reads:
TARO INVESTORS HAVE OPPORTUNITY TO LEAD TARO PHARMACEUTICAL INDUSTRIES LTD. SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Taro Pharmaceuti...
Taro Pharmaceutical
Informationen zu Product Placements
